MEDIUM confidence: 100% data completeness, but the composite (54) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Avg target $71 (last qtr, 17 analysts) → $75 (last mo, 7) (+6.2%).
Buy-rated share 36% → 38% over ~3 months (+2pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.09 | $2.51 | +130.3% |
| Apr 2026 | $2.23 | $3.37 | +51.1% |
| Feb 2026 | $-1.22 | $-1.19 | +2.5% |
| Oct 2025 | $-0.14 | $0.50 | +445.4% |
| Jul 2025 | $0.11 | $-0.16 | -243.4% |
| Apr 2025 | $2.52 | $2.90 | +15.1% |
| Feb 2025 | $0.44 | $0.80 | +81.8% |
| Oct 2024 | $1.33 | $1.62 | +21.8% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $126.0B— | $144.5B+14.7% | $154.0B+6.5% | $163.1B+5.9% | $194.8B+19.4% |
| EPS (dil.) | $2.28— | $2.07-9.2% | $4.95+139.1% | $6.31+27.5% | $-13.62-315.8% |
| Free Cash Flow | $3.3B— | $5.3B+59.5% | $7.3B+38.0% | -$490M-106.8% | $4.3Bn/m |
| Gross Margin | 11.3% | 11.5%+0.3pp | 11.2%-0.3pp | 10.3%-0.9pp | 12.2%+1.9pp |
| Operating Margin | 1.4% | 0.9%-0.5pp | 1.9%+1.0pp | 1.9%+0.0pp | -3.9%-5.9pp |
| Net Margin | 1.1% | 0.8%-0.2pp | 1.8%+0.9pp | 2.0%+0.3pp | -3.4%-5.5pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 2.6%/yr (revenue basis).
Base free cash flow $3.7B (avg FY2023–FY2025; latest year $4.3B) · equity value $33.1B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$5.2M over 180 days (0 open-market buys, 1 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 54 for Centene Corp indicates a neutral outlook, driven by a mix of positive and negative factors. The stock scores high on momentum, with a 12-month return of 165.6%, and exhibits strong risk characteristics, with a beta of 1.1 and moderate volatility. However, it trades at a low valuation, with a P/E of -6.4, and exhibits weak profitability, with an ROE of -24.0%. The long-term and short-term scores diverge, with the short-term score 9 points higher, suggesting a recent uptrend.